Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Moxifloxacin vs IV Cefazolin for Cellulitis
NCT00323219Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Jan 2004
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of moxifloxacin in cellulitis (2 arms), sponsored by University of British Columbia. Primary endpoint: Clinical cure at 7 days. Started Jan 2004; status: completed.
02
Drugs
moxifloxacin
03
Conditions
cellulitis
Beyond the preview
Go deeper on NCT00323219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323219.